特一药业：2022年归母净利润同比增40.41%，四季度止咳宝片等相关药品销量同期对比增长幅度较大
特一药业3月21日公告，2022年营业收入8.87亿元，同比增长16.94%；归母净利润1.78亿元，同比增长40.41%；基本每股收益0.8元，同比增长29.03%。公司自2022年第三季度以来，调整了营销策略和方案，加大了市场开拓和促销力度，取得了较好效果，特别是第四季度，公司加大了止咳退烧等相关药品的生产和市场供应，公司止咳宝片等相关药品销量同期对比增长幅度较大，导致收入增长的同时，为公司带来了较好的经营业绩。
Statement:
The content of this article does not represent the views of fxgecko website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!
5 analyst calls of the day: M&T Bank upgraded, Ollie's cut to Sell | Pro Recap By
U.S. stocks were rising after deal for SVB eases worries about banks By
Related News
